Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sublineage B.1.617.2 or Delta, a variant that began circulating in India and is becoming dominant in the USA, has been responsible for significant morbidity and mortality. In May 2021, the Delta variant was upgraded to a variant of concern...

Descripción completa

Detalles Bibliográficos
Autores principales: Landsberg, Hannah E., Turcinovic, Jacquelyn, Sullivan, Madison, Connor, John H., Hamer, Davidson H., Platt, Judy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556072/
https://www.ncbi.nlm.nih.gov/pubmed/34757200
http://dx.doi.org/10.1016/j.ijid.2021.10.053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556072/
https://www.ncbi.nlm.nih.gov/pubmed/34757200
http://dx.doi.org/10.1016/j.ijid.2021.10.053

Ejemplares similares